ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 80 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is 4.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20 | -16.7% | 24,000 | -5.9% | 0.00% | -20.0% |
| Q2 2023 | $24 | -14.3% | 25,500 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $28 | -26.3% | 25,500 | -5.6% | 0.01% | -33.3% |
| Q4 2022 | $38 | -99.9% | 27,000 | -5.3% | 0.01% | +12.5% |
| Q3 2022 | $31,000 | -36.7% | 28,500 | 0.0% | 0.01% | -33.3% |
| Q2 2022 | $49,000 | +19.5% | 28,500 | +42.5% | 0.01% | -7.7% |
| Q1 2022 | $41,000 | 0.0% | 20,000 | +81.8% | 0.01% | +8.3% |
| Q4 2021 | $41,000 | -51.2% | 11,000 | -30.5% | 0.01% | -36.8% |
| Q1 2021 | $84,000 | – | 15,825 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 6,287,101 | $4,903,939 | 2.63% |
| Syncona Portfolio Ltd | 1,377,294 | $1,074,289 | 1.60% |
| MPM BioImpact LLC | 5,095,912 | $3,974,811 | 1.06% |
| NEA Management Company, LLC | 17,079,778 | $13,322,227 | 1.03% |
| TANG CAPITAL MANAGEMENT LLC | 5,166,954 | $4,030,224 | 0.57% |
| PFM Health Sciences, LP | 10,423,135 | $8,130,045 | 0.38% |
| Matrix Capital Management Company, LP | 38,974,185 | $30,399,864 | 0.36% |
| Long Focus Capital Management, LLC | 10,963,158 | $8,551,263 | 0.31% |
| Acuitas Investments, LLC | 479,764 | $374,216 | 0.22% |
| Endurant Capital Management LP | 311,944 | $243,316 | 0.22% |